Clinical Trial Update: Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vitamin E, selenium, and soy protein for prevention in men with high-grade prostate neoplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Selenium (selenium)
• Soy protein (soy protein)
• Vitamin E (tocopherol)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Precancerous/Nonmalignant Condition, Prostate Cancer | Phase 3 | Status: COMPLETED